[Therapy of chronic lymphocytic leukemia].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002587:Cesium Isotopes / Q000627:therapeutic use; D003036:Cobalt Isotopes / Q000627:therapeutic use; D006658:Histoplasma / Q000302:isolation & purification; D006801:Humans; D007945:Leukemia, Lymphoid / Q000145:classification / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology / Q000532:radiotherapy; D011867:Radioisotope Teletherapy; D013154:Spleen / Q000473:pathology; D013897:Thoracic Duct / Q000276:immunology*; D005719:gamma-Globulins / Q000032:analysis / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D002587:Cesium Isotopes; D003036:Cobalt Isotopes; D005719:gamma-Globulins
La terapia della leucemia linfatica cronica.